Overview
Alister Hart practices practicing medicine in London, United Kingdom.
Hart is highly rated in 1 condition, according to our data. Their clinical expertise encompasses Peripheral T-Cell Lymphoma, Hip Resurfacing, and Hip Replacement.
They are actively involved in clinical research, co-authoring 10 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Alister J. Hart
Is Alister J. Hart a top-rated expert for Hip Resurfacing?
MediFind is an objective health platform that identifies experts based on real-world data. Alister J. Hart is classified as an Advanced expert for Hip Resurfacing, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Alister J. Hart participate in research or clinical trials?
Yes. Alister J. Hart has published 10 articles and abstracts on conditions like Hip Resurfacing. You can view a list of Alister J. Hart's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Hip ResurfacingHart isAdvanced. Learn about Hip Resurfacing.
- Experienced
- Hip ReplacementHart isExperienced. Learn about Hip Replacement.
- Peripheral T-Cell LymphomaHart isExperienced. Learn about Peripheral T-Cell Lymphoma.